Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Barrett

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Genome|October 1, 1994
Mitochondrial DNA diversity in the pea aphid Acyrthosiphon pisumR J Barrett, T J Crease, P D Hebert, et al.
American Journal of Clinical Oncology|December 1, 1993
A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group StudyL G Feun, J A Blessing, R J Barrett, et al.
Pharmacology, Biochemistry, and Behavior|October 13, 1998
Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptorsR L Smith, H Canton, R J Barrett, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1988
Cardiovascular and renal actions of calcium channel blocker chemical subgroups: a search for renal specificityR J Barrett, K F Wright, D R Taylor, et al.
Psychopharmacology|January 1, 1994
Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcementR J Barrett, W F Caul, E M Huffman, et al.
Pharmacological Research Communications|January 1, 1985
Lack of renal tubular and hemodynamic effects of non-selective and delta-opioid receptor antagonismR J Barrett, J A Turpin, B A McGuirk, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1974
p-Chloroamphetamine: evidence against a serotonin mediated learning deficit in PKUG J Schaefer, R J Barrett, E Sanders-Bush, et al.
The Journal of Infectious Diseases|August 23, 2001
Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapyA Weinberg, D A Wohl, R J Barrett, et al.
Psychopharmacology|October 18, 2001
Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding toleranceR J Barrett, W F Caul, J R Stadler, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonistR J Barrett, J M May, P L Martin, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Genome|October 1, 1994
Mitochondrial DNA diversity in the pea aphid Acyrthosiphon pisumR J Barrett, T J Crease, P D Hebert, et al.
American Journal of Clinical Oncology|December 1, 1993
A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group StudyL G Feun, J A Blessing, R J Barrett, et al.
Pharmacology, Biochemistry, and Behavior|October 13, 1998
Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptorsR L Smith, H Canton, R J Barrett, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1988
Cardiovascular and renal actions of calcium channel blocker chemical subgroups: a search for renal specificityR J Barrett, K F Wright, D R Taylor, et al.
Psychopharmacology|January 1, 1994
Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcementR J Barrett, W F Caul, E M Huffman, et al.
Pharmacological Research Communications|January 1, 1985
Lack of renal tubular and hemodynamic effects of non-selective and delta-opioid receptor antagonismR J Barrett, J A Turpin, B A McGuirk, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1974
p-Chloroamphetamine: evidence against a serotonin mediated learning deficit in PKUG J Schaefer, R J Barrett, E Sanders-Bush, et al.
The Journal of Infectious Diseases|August 23, 2001
Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapyA Weinberg, D A Wohl, R J Barrett, et al.
Psychopharmacology|October 18, 2001
Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding toleranceR J Barrett, W F Caul, J R Stadler, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonistR J Barrett, J M May, P L Martin, et al.
Pageof 15